TOPÇU, A. Et Al. 2021. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. FUTURE ONCOLOGY , vol.17 , 4157-4169.

TOPÇU, A., Atci, M. M., Secmeler, S., BEŞİROĞLU, M., Ayhan, M., ÖZKAN, M., ... BOZKURT, O.(2021). Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. FUTURE ONCOLOGY , vol.17, 4157-4169.

TOPÇU, Atakan Et Al. "Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer," FUTURE ONCOLOGY , vol.17, 4157-4169, 2021

TOPÇU, Atakan Et Al. "Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer." FUTURE ONCOLOGY , vol.17, pp.4157-4169, 2021

TOPÇU, A. Et Al. (2021) . "Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer." FUTURE ONCOLOGY , vol.17, pp.4157-4169.

@article{article, author={Atakan TOPÇU Et Al. }, title={Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer}, journal={FUTURE ONCOLOGY}, year=2021, pages={4157-4169} }